Hydrolases Segment has the Largest Share of Enzyme Type in the Middle East and Africa Medical Enzyme Technology Market during 2021–2028

According to a new market research study on “Middle East and Africa Medical Enzyme Technology Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Enzyme Type, and Application” is expected to reach US$ 245.2 million by 2028 from US$ 176.7 million in 2021. The market is estimated to grow at a CAGR of 4.8% from 2021 to 2028. The report provides trends prevailing in the Middle East and Africa Medical enzyme technology market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the growing applications of enzymes for disease treatment and as diagnostic tools, significant increase in research and development activities to boost the awareness about radiation therapy are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the handling and safety issues related to enzymes.

Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. These regions are developing in terms of the medical industry. The countries in these regions are highly dependent on medical devices and biopharmaceuticals products. Therefore, countries have faced several challenges for their requirements. Following COVID-19 and government actions, certain enzyme applications, such as pharmaceuticals and detergents, are likely to see an increase in demand. The increase in medical research and diagnostics has been a major factor in the increase in enzyme demand, as enzymes are widely used in medicine and pharmaceutical engineering. Some companies in the area are working with other businesses to consolidate all facilities under one roof for the convenience of the clients. DuBiotech, for example, is actively forming affiliations and partnerships with prestigious universities, specialist hospitals, global regulatory bodies, and other research parks to link the DuBiotech group with the global Life Sciences industry. DuBiotech includes a group of Biotechnology, Pharmaceutical, and Research firms, including global leaders such as Pfizer, Amgen, Merck Serono, and Genzyme, in keeping with its philosophy of being the major life science centre in the Middle East. Many small and medium-sized enterprises are also involved in the city. Such initiatives will help the gain traction for the medical enzymes technology market in near future.

The market for medical enzyme technology market is segmented into enzyme type, and application. Based on enzyme type, the medical enzyme technology market is segmented into digestive enzymes, thrombolytic enzymes, hydrolases, and endonucleases. The hydrolases segment is expected to emerge as the leading segment over the projected period. The large share of this segment can be attributed to the growing applications of enzymes for disease treatment and as diagnostic tools. In addition, the rising prevalence of cancer, increasing demand for cost effective treatment modes, and growing awareness among the population concerning the early diagnosis of disease. However, the thrombolytic enzymes segment is estimated the register the fastest CAGR during the forecast period.

Merck Kgaa, Thermo Fisher Scientific Inc., Novozymes, Takeda Pharmaceutical Company Limited, Agilent Technologies, Inc., Genzyme Corporation, Asahi Kasei Corporation, Promega Corporation, Cytiva, and Amano Enzyme Inc. are among the leading companies in the Middle East and Africa medical enzyme technology market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in March 2021, Amano Enzyme has introduced Umamizyme Pulse, a non-GMO enzyme engineered for use in a variety of plant protein products to produce a good, savoury (umami) flavour similar to that produced by monosodium glutamate (MSG), as well as a sensation of richness and complexity (kokumi). 

The market for medical enzyme technology market is segmented into enzyme type, and application. Based on enzyme type, the medical enzyme technology market is segmented into digestive enzymes, thrombolytic enzymes, hydrolases, and endonucleases. Based on application, the medical enzyme technology market is segmented into disease treatment, diagnostic tools, biomedical research, and others. Geographically, the medical enzyme technology market is segmented into Middle East and Africa (UAE, Saudi Arabia, South Africa, Rest of Middle East and Africa).